Here's Why Intersect ENT, Inc.'s Stock Cratered Today

What Shares of Intersect ENT , a drug device company focusing on developing therapeutic solutions for patients with ear, nose, and throat conditions, dropped by more than 26% today on exceptional volume. The apparent